311 related articles for article (PubMed ID: 26902498)
1. Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.
Zhou C; Zhang Y; Dai J; Zhou M; Liu M; Wang Y; Chen XZ; Tang J
Sci Rep; 2016 Feb; 6():22066. PubMed ID: 26902498
[TBL] [Abstract][Full Text] [Related]
2. Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion.
Chen J; Luo Q; Yuan Y; Huang X; Cai W; Li C; Wei T; Zhang L; Yang M; Liu Q; Ye G; Dai X; Li B
Mol Cell Biol; 2010 Dec; 30(24):5621-35. PubMed ID: 20937768
[TBL] [Abstract][Full Text] [Related]
3. The role of Pygopus 2 in rat glioma cell growth.
Chen YY; Li BA; Wang HD; Liu XY; Tan GW; Ma YH; Shen SH; Zhu HW; Wang ZX
Med Oncol; 2011 Jun; 28(2):631-40. PubMed ID: 20361361
[TBL] [Abstract][Full Text] [Related]
4. Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin.
Svoboda LK; Bailey N; Van Noord RA; Krook MA; Harris A; Cramer C; Jasman B; Patel RM; Thomas D; Borkin D; Cierpicki T; Grembecka J; Lawlor ER
Oncotarget; 2017 Jan; 8(1):458-471. PubMed ID: 27888797
[TBL] [Abstract][Full Text] [Related]
5. The MLL/Setd1b methyltransferase is required for the Spemann's organizer gene activation in Xenopus.
Lin H; Min Z; Tao Q
Mech Dev; 2016 Nov; 142():1-9. PubMed ID: 27519569
[TBL] [Abstract][Full Text] [Related]
6. hSETD1A regulates Wnt target genes and controls tumor growth of colorectal cancer cells.
Salz T; Li G; Kaye F; Zhou L; Qiu Y; Huang S
Cancer Res; 2014 Feb; 74(3):775-86. PubMed ID: 24247718
[TBL] [Abstract][Full Text] [Related]
7. Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.
Zhou C; Cheng H; Qin W; Zhang Y; Xiong H; Yang J; Huang H; Wang Y; Chen XZ; Tang J
Oncotarget; 2017 Apr; 8(17):27915-27928. PubMed ID: 28427190
[TBL] [Abstract][Full Text] [Related]
8. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
Wang T; Wu H; Liu S; Lei Z; Qin Z; Wen L; Liu K; Wang X; Guo Y; Liu Q; Liu L; Wang J; Lin L; Mao C; Zhu X; Xiao H; Bian X; Chen D; Xu C; Wang B
Cancer Lett; 2018 Aug; 430():11-24. PubMed ID: 29746925
[TBL] [Abstract][Full Text] [Related]
9. The SUMO-specific isopeptidase SENP3 regulates MLL1/MLL2 methyltransferase complexes and controls osteogenic differentiation.
Nayak A; Viale-Bouroncle S; Morsczeck C; Muller S
Mol Cell; 2014 Jul; 55(1):47-58. PubMed ID: 24930734
[TBL] [Abstract][Full Text] [Related]
10. Decreased pygopus 2 expression suppresses glioblastoma U251 cell growth.
Wang ZX; Chen YY; Li BA; Tan GW; Liu XY; Shen SH; Zhu HW; Wang HD
J Neurooncol; 2010 Oct; 100(1):31-41. PubMed ID: 20204459
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.
Dharmarajan V; Lee JH; Patel A; Skalnik DG; Cosgrove MS
J Biol Chem; 2012 Aug; 287(33):27275-89. PubMed ID: 22665483
[TBL] [Abstract][Full Text] [Related]
12. SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation.
Brès V; Yoshida T; Pickle L; Jones KA
Mol Cell; 2009 Oct; 36(1):75-87. PubMed ID: 19818711
[TBL] [Abstract][Full Text] [Related]
13. Regulation of MLL1 H3K4 methyltransferase activity by its core components.
Dou Y; Milne TA; Ruthenburg AJ; Lee S; Lee JW; Verdine GL; Allis CD; Roeder RG
Nat Struct Mol Biol; 2006 Aug; 13(8):713-9. PubMed ID: 16878130
[TBL] [Abstract][Full Text] [Related]
14. The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression.
Talla SB; Brembeck FH
Oncotarget; 2016 Dec; 7(49):80612-80632. PubMed ID: 27811361
[TBL] [Abstract][Full Text] [Related]
15. The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness.
Grinat J; Heuberger J; Vidal RO; Goveas N; Kosel F; Berenguer-Llergo A; Kranz A; Wulf-Goldenberg A; Behrens D; Melcher B; Sauer S; Vieth M; Batlle E; Stewart AF; Birchmeier W
Nat Commun; 2020 Dec; 11(1):6422. PubMed ID: 33349639
[TBL] [Abstract][Full Text] [Related]
16. FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway.
Wang M; Li C; Shi W
Biofactors; 2021 Jul; 47(4):600-611. PubMed ID: 33759248
[TBL] [Abstract][Full Text] [Related]
17. The Pygo2-H3K4me2/3 interaction is dispensable for mouse development and Wnt signaling-dependent transcription.
Cantù C; Valenta T; Hausmann G; Vilain N; Aguet M; Basler K
Development; 2013 Jun; 140(11):2377-86. PubMed ID: 23637336
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin-dependent acetylation of Pygo2 by CBP/p300 histone acetyltransferase family members.
Andrews PG; Kao KR
Biochem J; 2016 Nov; 473(22):4193-4203. PubMed ID: 27647933
[TBL] [Abstract][Full Text] [Related]
19. MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.
Chen Y; Anastassiadis K; Kranz A; Stewart AF; Arndt K; Waskow C; Yokoyama A; Jones K; Neff T; Lee Y; Ernst P
Cancer Cell; 2017 Jun; 31(6):755-770.e6. PubMed ID: 28609655
[TBL] [Abstract][Full Text] [Related]
20. Pygo2 siRNA Inhibit the Growth and Increase Apoptosis of U251 Cell by Suppressing Histone H3K4 Trimethylation.
Li M; Chao L; Wu J; Xu H; Shen S; Chen S; Gao X; Yu N; Wang Z
J Mol Neurosci; 2015 Aug; 56(4):949-955. PubMed ID: 25869613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
